Blast at Sigachi Industries Raises Concerns

On July 1, 2025, a tragic explosion occurred at the manufacturing facility of Sigachi Industries in Pashamylaram, resulting in numerous fatalities. The incident has ignited a renewed focus on safety protocols within the pharmaceutical industry in the region. The Factories Department is currently in the process of gathering evidence regarding the event, while various experts have analyzed footage from the site and concluded that the explosion was likely a "dust explosion" rather than a "Boiling Liquid Expanding Vapour Explosion" (BLEVE), which was the initial explanation given by the authorities.

Key details are as follows:

• Incident Details: The explosion at Sigachi Industries resulted in several deaths, prompting investigations into safety practices within the pharmaceutical sector.

• Expert Opinions:

  • Zuber Ali Khan, a fire forensics expert, argued that the incident was a dust explosion, which can produce significant effects, including the outward and inward force seen at the blast site.
  • Retired scientist K. Babu Rao supported Khan's view, explaining that the production process involves hot air that removes moisture from microcrystalline cellulose (MCC) powder. The potential for a dust explosion increases when dust accumulates in confined spaces under certain conditions.

• Technical Insights:

  • A dust explosion can occur at an ignition temperature as low as 232°C, necessitating strict temperature controls during the production process.
  • Babu Rao estimates that the energy released by the explosion was equivalent to a 400 kg TNT blast.

• Regulatory Criticism:

  • Both experts have criticized the Factories Department for inadequate inspection and oversight, alleging that they have often issued favorable reports to companies despite ongoing safety issues.
  • Babu Rao highlighted the lack of progress regarding a report from an expert committee that was formed after a separate explosion at SB Organics Limited in April 2024, reflecting persistent safety concerns in the industry.

• Historical Context: The Factories Department had previously attributed a different explosion to static electricity, assigning blame to the workers for not wearing safety gear rather than addressing systemic safety failures within the company.

In summary, the explosion at Sigachi Industries underscores the pressing need for stringent safety protocols within the pharmaceutical industry, particularly in light of past incidents. The conflicting assessments regarding the cause of the explosion illustrate the importance of thorough investigations and regulatory compliance to prevent future tragedies.

Key Points:

• Date of Incident: July 1, 2025.
• Location: Sigachi Industries, Pashamylaram.
• Casualties: Dozens reported killed.
• Expert Conclusions:
  • Likely a dust explosion due to accumulation and confined space conditions.
  • BLEVE theory retracted by experts.
• Safety Concerns:
  • Ignition temperature for dust explosion is 232°C.
  • Safety protocols inadequately enforced by the Factories Department.
• Regulatory Failures:
  • Inconsistent safety inspections and accountability issues highlighted by experts.
• Historical Precedents: Previous explosions lead to similar regulatory criticisms without much actionable response.